Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Accelerated Infliximab Infusions in IBD
NCT01346826Phase 4Completed
- Sponsor
- Asan Medical Center
- Start
- May 2011
- Primary completion
- Oct 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of infliximab in Crohn's disease, ulcerative colitis (UC), sponsored by Asan Medical Center. Started May 2011; status: completed.
02
Drugs
infliximab
03
Conditions
Crohn's diseaseulcerative colitis (UC)
Beyond the preview
Go deeper on NCT01346826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01346826.